Acknowledgments The authors express their thanks to Drs Eckhardt Ferdinandi and Claude Larose (formerly of Theratechnologies Inc.) for providing the GLP-1 receptors agonists labelled above as G001 and G002, to Olga Plaskon, Estera Karolczyk, Kasia Zajkowska and Gurpal Bansal for technical assistance, and to Professor Huw Jones, Middlesex University for help with statistical analyses
Early studies suggest links to improved glucose metabolism and better control of cravings
Belkoff after a comprehensive consultation and lab review
Ruggenenti, P., Cattaneo, D., Loriga, G., Ledda, F., Motterlini, N., Gherardi, G., Orisio, S., & Remuzzi, G